COVID-19 & Research Restart

OVCR Research-Related Updates Regarding COVID-19 Emergency and Research Restart

Information for Campus Research Restart

Updated: August 20, 2020

Phase 4 of Restore Illinois and Protecting Chicago COVID-19 recovery plans began on July 6th, allowing a limited capacity restart of human subjects research studies previously placed on hold. To apply to reopen closed protocols: https://uic.infoready4.com/#applicationForms/1817478. 

OVCR Offices of Sponsored Programs (OSP), Research Development Services and Postdoctoral Research, and the Office for the Protection of Research Subjects (OPRS) continue to provide all regular services. Similarly, all Compliance Offices (conflict of interest/affiliation, export control, IACUC and IBC, and research integrity) continue to be fully operational. BRL is operating at regular levels of services and capacity for new projects and orders. Building safety, entrance and health requirements for working in the facilities are posted at entrances. The COM Department for Microbiology and Immunology, OVCR/BRL and EHSO have worked together to open a BRL-affiliated BSL3 facility for SARS/COV-2 pathogen studies. The SARS/COV-2 BSL3 facility is now available for EHSO-trained researchers and IBC-approved projects. RRC cores are open for all projects, although most of our shared facilities are operating at slightly lower capacity due to guidelines for physical distancing, staffing and PPE. Some sample drop-offs and protocols may vary in order to lower risk of COVID-19 transmission for staff and researchers. Procedures for trained users of RRC instrumentation are available in each facility.  Any questions for BRL and RRC services should be sent to Dr. Jeff Fortman and/or the individual RRC Core Directors, respectively.